Chester County News and Community Website
PLYMOUTH MEETING, PA — Harmony Biosciences (Nasdaq: HRMY) announced its recent acquisition of Epygenix Therapeutics, Inc., marking a significant step into the rare epilepsy sector. This acquisition not only broadens …
Harmony Biosciences Expands into Rare Epilepsy Market with Epygenix Therapeutics Acquisition Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has released their Q1 2024 report indicating a 30% year-over-year growth in net revenue, sealing the quarter ending March 31, …
Rapidly Growing Harmony Biosciences Sees 30% Increase in Net Revenue, Boosts Growth Strategy With Rare Epilepsy Franchise Acquisition Read More PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) announced it will release its first quarter 2024 financial results on Tuesday, April 30, 2024, ahead of the U.S. market …
Harmony Biosciences to Unveil Q1 2024 Financial Results Read More